Carmustine Kit
Product Images NDC 0781-3474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 0781-3474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Figure 1)

Structure (Figure 1)
FDA Label Image

Diluent (Figure 10)

Diluent (Figure 10)
This is a description of a medical product, specifically NDC 0781-3473-93. The product is Dehydrated Alcohol Injection, USP, used as a sterile diluent for Carmustine for Injection, USP. It is only available by prescription. The enclosed package insert should be read and the product should be stored in a refrigerator between 2° and 8°C (36" to &5°F). The product was manufactured by Sandoz Pharmaceutical Company located in Princeton, NJ. The Lot number is represented by the letter X.*
FDA Label Image

Powder (Figure 11)

Powder (Figure 11)
NDC 0781-3470-90 Carmustine for Injection, USP is a refrigerated cytotoxic agent available in a single-dose vial containing 100mg per vial, for intravenous infusion after reconstitution. The reconstituted solution can be stored in a refrigerator at 2° to 8°C for 24 hours. The usual dosage and precautions should be followed as per the enclosed package insert. The vial should be examined for particle formation after reconstitution and discarded if observed. It is manufactured by Jiangsu Hengr Pharmaceuticals Ltd, Lianyungang, Jiangsu, China, for Sandoz Inc, Princeton, NJ. Gloves should be worn while handling containers, and the product should be protected from light. The container closure uses a synthetic rubber formulation in lieu of natural rubber latex.*
FDA Label Image

Carton (Figure 12)

Carton (Figure 12)
This is a description of Carmustine for Injection, USP, a cytotoxic agent that comes 100 mg per vial. The carton comes with 1 vial of Carmustine for Injection, USP 100 mg and 1 vial of Sterile Diluent for Carmustine for Injection, USP 3 mL. The box has instructions for dosage, indications, and precautions. The drug must be refrigerated immediately after purchase, and unused portions should be discarded. It is essential to wear gloves when handling containers. Each single-dose vial contains 100 mg of Carmustine. After reconstitution, the drug is stable for 24 hours under refrigeration. If crystals form, they can be redissolved by warming the vial to room temperature with agitation. The container closure is not made of natural rubber latex. The drug is manufactured by Jiangsu Hengri Pharmaceuticals Co., Ltd, in Lianyungang, Jiangsu, China, and distributed by Sandoz Inc. in Princeton, NJ.*
FDA Label Image

Step 1 (Figure 2)

Step 1 (Figure 2)
Carmustine for Injection, USP is a medication available in a package that combines a 100 mg/vial combikit of the product with a diluent. The full description of the package is not available as the text is incomplete.*
FDA Label Image

Step 2 (Figure 3)

Step 2 (Figure 3)
This appears to be a label for a medical product, specifically a combination kit for Carmustine injection. The kit likely includes a diluent for preparing the injection.*
FDA Label Image

Step 3 (Figure 4)

Step 3 (Figure 4)
FDA Label Image

Step 4 (Figure 5)

Step 4 (Figure 5)
Carmustine for Injection, USP is a medication provided in a CombiKit form consisting of both product and diluent. Each vial contains 100 mg of the active ingredient. Further information about the use and administration of this medication should be obtained from a qualified healthcare professional.*
FDA Label Image

Step 5 (Figure 6)

Step 5 (Figure 6)
Carmustine for Injection, USP is a medication that is available in a 100 mg/vial dosage. It is provided in a COMBIKIT that includes both product and diluent.*
FDA Label Image

Step 6 (Figure 7)

Step 6 (Figure 7)
Carmustine for Injection, USP is a medication used for treating certain types of cancer. It is administered by injection and must be diluted before use. The diluent for Carmustine for Injection, USP is not specified in the provided text.*
FDA Label Image

Step 7 (Figure 8)

Step 7 (Figure 8)
This is a product description for Carmustine for Injection, USP. The kit contains a 100mg/vial of the medication and a 3mL vial of diluent for injection. This combination can be used for medical treatment purposes.*
FDA Label Image

Step 8 (Figure 9)

Step 8 (Figure 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.